Yousif Capital Management’s Haemonetics HAE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$990K Sell
13,203
-832
-6% -$53.4K 0.01% 1069
2026
Q1
$791K Sell
14,035
-936
-6% -$61K 0.01% 1177
2025
Q4
$1.05M Sell
14,971
-612
-4% -$41.1K 0.01% 1055
2025
Q3
$760K Sell
15,583
-1,774
-10% -$110K 0.01% 1244
2025
Q2
$1.3M Sell
17,357
-345
-2% -$22.8K 0.01% 985
2025
Q1
$1.12M Sell
17,702
-572
-3% -$38.9K 0.01% 1041
2024
Q4
$1.43M Sell
18,274
-1,224
-6% -$98.3K 0.02% 945
2024
Q3
$1.57M Sell
19,498
-2,350
-11% -$190K 0.02% 903
2024
Q2
$1.81M Sell
21,848
-1,628
-7% -$143K 0.02% 814
2024
Q1
$2M Sell
23,476
-501
-2% -$39.3K 0.02% 811
2023
Q4
$2.05M Buy
23,977
+73
+0.3% +$6.31K 0.02% 804
2023
Q3
$2.14M Sell
23,904
-1,230
-5% -$110K 0.03% 703
2023
Q2
$2.14M Sell
25,134
-816
-3% -$69K 0.03% 731
2023
Q1
$2.15M Sell
25,950
-165
-0.6% -$13.4K 0.03% 723
2022
Q4
$2.05M Sell
26,115
-260
-1% -$20.9K 0.03% 745
2022
Q3
$1.95M Sell
26,375
-2,389
-8% -$172K 0.03% 757
2022
Q2
$1.88M Buy
28,764
+2,125
+8% +$126K 0.02% 866
2022
Q1
$1.68M Buy
26,639
+195
+0.7% +$10.6K 0.02% 1061
2021
Q4
$1.4M Buy
+26,444
New +$1.61M 0.01% 1210

Other funds holding HAE

Yousif Capital Management's HAE Position: Q2 2026 in Review

Yousif Capital Management reduced its Haemonetics (HAE) stake by 5.9% in Q2 2026, selling an estimated $53.4K and leaving 13,203 shares worth $990K. The position accounts for 0.01% of the portfolio, ranked #1069.

Yousif Capital Management first reported a position in HAE in Q4 2021 and has held it in 19 quarters since. The position peaked at $2.15M in Q1 2023. 31 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Yousif Capital Management held 13,203 shares of Haemonetics worth $990K as of Q2 2026.
  • Yousif Capital Management sold 832 Haemonetics shares in Q2 2026, an estimated $53.4K.
  • Haemonetics made up 0.01% of Yousif Capital Management's portfolio in Q2 2026, its #1069 holding.
  • Yousif Capital Management first reported a position in Haemonetics in Q4 2021 and has held it in 19 quarters since.
  • Yousif Capital Management's Haemonetics position peaked at $2.15M in Q1 2023.
  • 31 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Yousif Capital Management's 13F filing for Q2 2026, filed 16 Jul 2026.